BRW (Saba Capitalome & Opportunities Fund) Change In Receivables : $0.94 Mil (TTM As of Oct. 2024)

View and export this data going back to . Start your Free Trial

What is Saba Capitalome & Opportunities Fund Change In Receivables?

Saba Capitalome & Opportunities Fund's change in receivables for the quarter that ended in Oct. 2024 was $65.79 Mil. It means Saba Capitalome & Opportunities Fund's Accounts Receivable declined by $65.79 Mil from Apr. 2024 to Oct. 2024 .

Saba Capitalome & Opportunities Fund's change in receivables for the fiscal year that ended in Oct. 2024 was $0.94 Mil. It means Saba Capitalome & Opportunities Fund's Accounts Receivable declined by $0.94 Mil from Oct. 2023 to Oct. 2024 .

Saba Capitalome & Opportunities Fund's Accounts Receivable for the quarter that ended in Oct. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Saba Capitalome & Opportunities Fund's Days Sales Outstanding for the six months ended in Oct. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Saba Capitalome & Opportunities Fund's liquidation value for the six months ended in Oct. 2024 was $-356.17 Mil.

Saba Capitalome & Opportunities Fund Change In Receivables Historical Data

The historical data trend for Saba Capitalome & Opportunities Fund's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saba Capitalome & Opportunities Fund Change In Receivables Chart

Saba Capitalome & Opportunities Fund Annual Data

Trend

Feb18

Feb19

Feb20

Feb21

Oct22

Oct23

Oct24

Change In Receivables

Get a 7-Day Free Trial

0.45

0.68

-8.45

-305.06

0.94

Saba Capitalome & Opportunities Fund Semi-Annual Data
	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Apr22	Oct22	Apr23	Oct23	Apr24	Oct24
Change In Receivables	Get a 7-Day Free Trial										-5.15	-52.73	-252.33	-64.85	65.79

Saba Capitalome & Opportunities Fund Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Oct. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.94 Mil.

Saba Capitalome & Opportunities Fund (NYSE:BRW) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Saba Capitalome & Opportunities Fund's Days Sales Outstanding for the quarter that ended in Oct. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	29.299	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Saba Capitalome & Opportunities Fund's accounts receivable are only considered to be worth 75% of book value:

Saba Capitalome & Opportunities Fund's liquidation value for the quarter that ended in Oct. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	8.348	-	364.519	+	0.75 * 0	+	0.5 * 0
=	-356.17

Saba Capitalome & Opportunities Fund Change In Receivables Related Terms

Thank you for viewing the detailed overview of Saba Capitalome & Opportunities Fund's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Saba Capitalome & Opportunities Fund Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Saba Capital Income & Opportunities Fund (NYSE:BRW) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

405 Lexington Avenue, 58th Floor, New York, NY, USA, 10174

Website

https://www.sabacef.com

Saba Capital Income & Opportunities Fund is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.

Executives

Boaz Weinstein	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Troy M Statczar	officer: Principle Financial Officer	3 CANAL PLAZA, PORTLAND ME 04101
Nitin Sapru	officer: Vice President	405 LEXINGTON AVE, 58TH FLOOR, NEW YORK NY 10174
Michael D'angelo	officer: Secretary	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Patrick J Keniston	officer: Chief Compliance Officer	FORESIDE COMPLIANCE SERVICES, LLC, THREE CANAL PLAZA, SUITE 100, PORTLAND ME 04101
Pierre Weinstein	officer: Chief Executive Officer	C/O SABA CAPITAL MANAGEMENT L.P., 405 LEXINGTON AVENUE, 5TH FLOOR, NEW YORK NY 10174
Christopher P Sullivan	other: Former Trustee	27 LEE TERRACE, SHORT HILLS NJ 07078
Thomas Bumbolow	director	C/O VOYA PRIME RATE TRUST, 7337 EAST DOUBLETREE RANCH RD., STE 100, SCOTTSDALE AZ 85258
Neal Neilinger	director	126 CLAPBOARD RIDGE ROAD, GREENWICH CT 06830
Charles I Clarvit	director	TWO INTERNATIONAL PLACE, BOSTON MA 02110
Kieran Goodwin	director	925 PARK AVENUE 11B, NEW YORK NY 10028
Ketu Desai	director	999 RIVERVIEW DR, SUITE 201, TOTOWA NJ 07512
Karen Caldwell	director	10125 SOUTH BELL AVENUE, CHICAGO IL 60643
Aditya Bindal	director	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174